Evelo Biosciences completes 1-for-20 reverse stock split; trading begins June 30

Evelo Biosciences, Inc.

Approved by stockholders on June 8, 2023; Board set ratio at 1-for-20 on June 27.
Reverse stock split became effective at 5:00 pm ET on June 29, 2023.
Every 20 existing shares converted into 1 share; no fractional shares issued, cash in lieu.
Trading on split-adjusted basis expected to start June 30 under symbol EVLO; new CUSIP: 299734202.
Number of authorized shares and par value unchanged; adjustments made to equity awards and warrants.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Evelo Biosciences, Inc.: Effected a 1-for-20 reverse stock split by filing a Certificate of Amendment to the Restated Certificate of Incorporation (effective 2023-06-29).

Change: charter amendment
Effective: 2023-06-29

Exact text from the filing

On June 29, 2023, the Company filed with the Secretary of State of the State of Delaware a certificate of amendment (the “ Certificate of Amendment ”) to amend the Company’s Certificate of Incorporation to effect the Reverse Stock Split. The Reverse Stock Split became effective at 5:00 p.m., Eastern Time, on June 29, 2023.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001694665-23-000100

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.